Albert Eilender - Adicet Bio Chairman of the Board

ACET
 Stock
  

USD 15.40  0.06  0.39%   

  Chairman
Mr. Albert L. Eilender was appointed Director of the Company effective July 1, 2018. He was the Chairman of the Board since October 2009. He joined the Board in 2000, was the lead independent director from 2005 to September 2009 and served as Chief Executive Officer of the Company from September 2010 to January 2013. He is the sole owner of Waterways Advisory Services, a firm specializing in advising companies on developing and evaluating options relative to mergers, acquisitions and strategic partnerships in the chemical industry. Mr. Eilender has not been active in the operations of this enterprise since October 2009. He has more than 35 years of diverse senior level experience in the specialty chemicals and pharmaceutical industry and has had direct financial responsibility, with significant experience in mergers, acquisitions and joint ventures, both domestically and internationally. He has also served on the boards of numerous industry trade associations during his career. We believe that Mr. Eilenders past 25 years of industry experience in executive management for operations within all three segments of Acetos business, as well as operations in North America, Europe and Asia, coupled with his experience in the areas of business consultation and mergers and acquisitions, and his service on the Board since 2000, give him the qualifications and skills to serve as one of our directors. In addition, as a director of Aceto he has demonstrated leadership within the Board and the ability to work effectively with management to create unity of effort.
Age: 72  Chairman Since 2018      
650 503-9095  www.restorbio.com

Adicet Bio Management Efficiency

Adicet Bio has return on total asset (ROA) of (7.15) % which means that it has lost $7.15 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (13.18) %, meaning that it created substantial loss on money invested by shareholders. Adicet Bio management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -32.1 in 2022. Return on Average Assets is likely to drop to -0.23 in 2022. Total Liabilities is likely to drop to about 32.6 M in 2022. Current Liabilities is likely to drop to about 16.1 M in 2022
The company currently holds 20.58 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Adicet Bio has a current ratio of 26.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Adicet Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Adicet Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adicet Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adicet to invest in growth at high rates of return. When we think about Adicet Bio's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CHAIRMAN Since

Andrew BryantIntel Corp
2012
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people. Adicet Bio (ACET) is traded on NASDAQ Exchange in USA. It is located in 200 Clarendon Street, Floor 6, Boston, MA 02116, United States and employs 86 people. Adicet Bio was previously known as ADICET BIO INC and was traded on NASDAQ Exchange under the symbol TORC. Adicet Bio is listed under Pharmaceutical Products category by Fama And French industry classification.

Adicet Bio Leadership Team

Elected by the shareholders, the Adicet Bio's board of directors comprises two types of representatives: Adicet Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adicet. The board's role is to monitor Adicet Bio's management team and ensure that shareholders' interests are well served. Adicet Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adicet Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Edward Borkowski, CFO
Rebecca Roof, Interim CFO
Hans Noetzli, Lead Independent Director
Douglas Roth, CFO, Principal Accounting Officer, Chief Admin. Officer, Sr. VP, Treasurer and Assistant Secretary
Natasha Giordano, Director
Alan Levin, Independent Director
Daniel Yarosh, Director
Salvatore Guccione, CEO and President and Director
Albert Eilender, Chairman of the Board
Jody Burfening, IR Contact Officer
William Britton, Independent Director
Terry Kippley, Senior Vice President - Agricultural Protection Products
Frances Scally, Chief Accounting Officer
Satish Srinivasan, President and COO of Rising Pharmaceuticals
Frank DeBenedittis, Sr. VP of Corporate Bus. Devel. and International Sr. VP of Active Pharmaceutical Ingredients
Richard Randall, Independent Director
Carlos Restrepo, Senior Vice President - Performance Chemicals
Vimal Kavuru, President of Rising
Nicholas Shackley, Senior Vice President - Pharmaceutical Ingredients
Steven Rogers, Sr. VP, General Counsel and Corporate Secretary
Walter Kaczmarek, COO
William Kennally, Director
Charles Alaimo, Senior Vice President - Human Resources
Fran Scally, Chief Accounting Officer
Raymond Bartone, Senior Vice President - Nutritionals

Adicet Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adicet Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Adicet Bio Investors Sentiment

The influence of Adicet Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Adicet. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Adicet Bio's public news can be used to forecast risks associated with investment in Adicet. The trend in average sentiment can be used to explain how an investor holding Adicet can time the market purely based on public headlines and social activities around Adicet Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Adicet Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adicet Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Adicet Bio's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Adicet Bio.

Adicet Bio Implied Volatility

    
  287.31  
Adicet Bio's implied volatility exposes the market's sentiment of Adicet Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adicet Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adicet Bio stock will not fluctuate a lot when Adicet Bio's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adicet Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adicet Bio's short interest history, or implied volatility extrapolated from Adicet Bio options trading.

Pair Trading with Adicet Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adicet Bio

0.71ALXOAlx Oncology Holdings Aggressive PushPairCorr
0.87ARWRArrowhead Pharma Fiscal Year End 28th of November 2022 PairCorr

Moving against Adicet Bio

0.74AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr
0.61ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
0.51ACBAurora Cannabis Fiscal Year End 26th of September 2022 PairCorr
The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.
The correlation of Adicet Bio is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
616.5 M
Quarterly Revenue Growth YOY
0.011
Return On Assets
-0.1
Return On Equity
-0.18
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Adicet Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.